Scinai Immunotherapeutics (SCNI) Operating Expenses (2014 - 2026)
Scinai Immunotherapeutics (SCNI) posted Operating Expenses of -$1.3 million for Q1 2026, down 93.54% sequentially from -$697000.0 in Q2 2025, and up 24.89% YoY from -$1.1 million in Q1 2025.
Scinai Immunotherapeutics (SCNI) Operating Expenses (2014 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Operating Expenses for 13 years, with the latest figure at -$1.3 million in Q1 2026.
- Quarterly Operating Expenses rose 24.89% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (down 188.65% YoY) and the FY2025 annual result came in at -$5.4 million, down 167.15% from the prior year.
- Operating Expenses eased to -$1.3 million in Q1 2026 per SCNI's latest filing, from -$697000.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $17.6 million in Q4 2023 and troughed at -$14.8 million in Q3 2022.
- A 5-year average of $2.1 million and a median of $1.9 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 159.81% in 2023, then slumped 320.39% in 2024.
- Over 5 years, Operating Expenses stood at $6.8 million in 2022, then jumped by 159.81% to $17.6 million in 2023, then decreased by 20.29% to $14.0 million in 2024, then slumped by 104.97% to -$697000.0 in 2025, then plunged by 93.54% to -$1.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered -$1.3 million, -$697000.0, and -$1.8 million for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Scinai Immunotherapeutics | 1.08 Mn | -3.11 Bn | -1.12 Mn | -1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 Mn |
| Jun 30, 2025 | -697,000.00 |
| Mar 31, 2025 | -1.80 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Sep 30, 2024 | -2.17 Mn |
| Jun 30, 2024 | -5.72 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 17.59 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Jun 30, 2023 | 2.60 Mn |
| Mar 31, 2023 | 3.19 Mn |
| Dec 31, 2022 | 6.77 Mn |
| Sep 30, 2022 | -14.78 Mn |
| Jun 30, 2022 | 10.78 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | -13.02 Mn |
| Sep 30, 2021 | 8.23 Mn |
| Jun 30, 2021 | 8.90 Mn |
| Mar 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | 16.09 Mn |